WEAV:NYE-Weave Communications Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 9

Change

0.00 (0.00)%

Market Cap

USD 0.63B

Volume

0.30M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
VEEV Veeva Systems Inc Class A

+1.82 (+0.98%)

USD 29.06B
SOLV Solventum Corp.

-1.05 (-2.01%)

USD 10.78B
DOCS Doximity Inc

+0.02 (+0.07%)

USD 5.13B
EVH Evolent Health Inc

-0.46 (-2.04%)

USD 2.52B
TDOC Teladoc Inc

+0.65 (+6.69%)

USD 1.70B
PHR Phreesia Inc

+0.01 (+0.05%)

USD 1.16B
MPLN MultiPlan Corporation

N/A

USD 0.25B
AMWL American Well Corp

+0.04 (+9.46%)

USD 0.11B
OWLT Owlet Inc

-0.14 (-3.30%)

USD 0.04B
FOXO FOXO Technologies Inc.

N/A

USD 3.08M

ETFs Containing WEAV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.53% 50% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.53% 50% F 8% B-
Trailing 12 Months  
Capital Gain 9.49% 90% A- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.49% 90% A- 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 35.07% 90% A- 92% A
Dividend Return 35.07% 90% A- 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 70.81% 30% F 11% F
Risk Adjusted Return 49.53% 90% A- 71% C-
Market Capitalization 0.63B 45% F 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector